Icon

BELBUCA (nda207932)- (EQ 0.075MG BASE,EQ 0.15MG BASE,EQ 0.3MG BASE,EQ 0.45MG BASE,EQ 0.6MG BASE,EQ 0.75MG BASE,EQ 0.9MG BASE)

BUPRENORPHINE HYDROCHLORIDE BDSI
EQ 0.075MG BASE,EQ 0.15MG BASE,EQ 0.3MG BASE,EQ 0.45MG BASE,EQ 0.6MG BASE,EQ 0.75MG BASE,EQ 0.9MG BASE
Yes Yes
2032-Dec-21 Expired
None 2018-Oct-23
None No
BELBUCA buccal film contains buprenorphine, a partial opioid agonist. BELBUCA is indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate
1 0 0
Total Other Developers 2
Drugs with Suitability No
EQ 0.075MG BASE ** ** Up - -
EQ 0.15MG BASE ** ** Up - -
EQ 0.3MG BASE ** ** Up - -
EQ 0.45MG BASE ** ** Up - -
EQ 0.6MG BASE ** ** Up - -
EQ 0.75MG BASE ** ** Up - -
EQ 0.9MG BASE ** ** Up - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.